Wilate® is a 1:1 balanced mixture of von Willebrand factor and coagulation factor VIII registered in Switzerland for prophylaxis and treatment of bleeding in patients suffering from von Willebrand disease and haemophilia A. The gene discussed is VWF; the disease is hemophilia A.